1000004099

Biocon

366.85
-9.20 (-2.45%) tick NSE

Last updated on 20 Jan 2026 11:40 PM

Returns
-2.63%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

56709.94

Earning Per Share

5.06

Dividend Yield

0.11%

P/E Ratio

74.31

P/B Ratio

1.68

Debt to Equity

0.62

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value
down-img

5.34% down side

up side5.34%

ups-img

About the company

Biocon Limited is India's largest and fully-integrated, innovation-led biopharmaceutical company. At present, Company is engaged in the manufacture of biotechnology products and research services. Biocon Limited was incorporated in 1978 as a joint venture between Biocon Biochemicals Limited of Ireland and an Indian entrepreneur, Kiran Mazumdar-Shaw. Biocon manufactured and exported enzymes to USA and Europe during the year 1979, as first of its kind. In 1989, Unilever plc acquired the Biocon Biochemicals Limited in Ireland and merges it with its subsidiary, Quest International.

Similar Companies